Inactief instrument

Andere talen ContraVir Pharmaceuticals Inc Nasdaq

Aandelen

US21234W1036

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Hepion Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	21/05
Sector Update: Health Care Stocks Increase Late Afternoon	22/04
Sector Update: Health Care	22/04
Top Midday Decliners	22/04
Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b 'ASCEND-NASH' Trial	22/04
North American Morning Briefing: Stock Futures Rise, Busy Week of Earnings Ahead	22/04
Hepion Pharmaceuticals Starts Wind-Down Activities in Phase 2b ASCEND-NASH Trial	19/04
Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial	19/04
Hepion Pharmaceuticals, Inc. Initiates Wind-Down Activities in Phase 2b ?ASCEND-NASH? Trial	19/04
Hepion Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	16/04
Hepion Pharmaceuticals Strengthens Board of Directors with Appointment of Michael Purcell	06/03
Hepion Pharmaceuticals, Inc. Appoints Michael Purcell to Its Board of Directors	06/03
Hepion Pharmaceuticals, Inc. Announces Board Changes	20/02
Hepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross Proceeds	16/02
Hepion Pharmaceuticals, Inc. Announces Resignation of Anand Reddi from the Board of Directors	07/02
Hepion Pharmaceuticals to Present at NASH-TAG 2024	03/01
North American Morning Briefing : Futures Pause -2-	08/12
Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value	07/12
Hepion Pharmaceuticals Approves Restructuring Plan to Preserve Capital, Launches Strategic Review Process	07/12
Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes	07/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen ContraVir Pharmaceuticals Inc Nasdaq

Aandelen

US21234W1036

Andere talen

Filters